| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |